CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy – Reuters
TrustVaccines
via vaccines https://ift.tt/367nw4O
June 17, 2021 at 05:34AM
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy – Reuters
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy – Reuters
TrustVaccines
via vaccines https://ift.tt/367nw4O
June 17, 2021 at 05:34AM
Welcome to vaccine education 